STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Genpact and STADA Renew Multi-Year Partnership to Enhance Finance Operations

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
partnership

Genpact (NYSE: G) and STADA (SAZ.DE) have renewed their multi-year partnership to enhance STADA's finance operations. The collaboration aims to derisk, scale, and simplify STADA's financial processes, driving competitive advantages. Since 2019, Genpact has leveraged automation and process-harmonization to improve STADA's critical operations, implementing technologies like Genpact's Cora APFlow.

The partnership has enhanced accuracy in accounts payable and receivable, improved data transparency, and allowed STADA's teams to focus on strategic initiatives. Genpact's expertise has been important in optimizing STADA's finance and procurement processes, from supplier invoicing to financial reporting. The companies are also collaborating on implementing advanced tools like S4HANA and generative AI.

Loading...
Loading translation...

Positive

  • Renewal of multi-year partnership between Genpact and STADA
  • Implementation of automation and process-harmonization technologies
  • Improved accuracy in critical processes like accounts payable and receivable
  • Enhanced data transparency and streamlined operations
  • Collaboration on implementing advanced tools like S4HANA and generative AI

Negative

  • None.

News Market Reaction 1 Alert

-0.41% News Effect

On the day this news was published, G declined 0.41%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Leveraging Genpact's data, technology and AI expertise to future-proof STADA's finance organization and drive competitive advantages

NEW YORK, Sept. 12, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, and STADA (SAZ.DE), a leading manufacturer of consumer healthcare, generic and specialty pharma medicines, today announced the renewal of a multi-year partnership. The new chapter of innovation is aimed at further derisking, scaling, and simplifying STADA's finance operations to drive competitive advantages.

"Genpact has enabled us to handle end-to-end tasks efficiently and cost-effectively," - Boris Döbler, Group CFO, STADA.

"This renewal exemplifies our leadership in finance and accounting services," said Sanjiv Tandon, Global Business Unit Leader, Life Sciences and Healthcare, Genpact. "By combining this expertise with our digital leadership and industry knowledge, we will enhance STADA's decision-making with actionable finance data, automate key F&A processes, and support regulatory compliance – ultimately enabling the company to continuously scale and excel in its industry."

Since 2019, Genpact's partnership with STADA has centered on leveraging automation and process-harmonization to enhance critical operations. Implementing technologies such as Genpact's Cora APFlow has improved the accuracy of critical processes such as accounts payable and receivable, streamlined data transparency, and empowered STADA's teams to focus on strategic initiatives that drive business outcomes.

"STADA's rapid growth and complex operations require a scalable and efficient platform. Our partnership with Genpact has enabled us to create automated processes that handle end-to-end tasks like procure-to-pay and order-to-cash efficiently and cost-effectively," said Boris Döbler, Group Chief Financial Officer, STADA. "This allows our internal teams to focus on high-value activities. By leveraging data, analytics, and process automation, we're not only reducing costs but also improving accuracy, quality, and customer satisfaction."

Genpact has been instrumental in optimizing STADA's finance and procurement processes, from supplier invoicing to financial reporting, leveraging advanced technology and deep finance and accounting expertise. Based on this strong foundation, the companies also are partnering to implement and leverage tools and technologies like S4HANA and generative AI.

For more information on Genpact's capabilities and services for the life sciences and healthcare industries, visit here.

About Genpact
Genpact (NYSE: G) is a global professional services and solutions firm delivering outcomes that shape the future. Our 125,000+ people across 30+ countries are driven by our innate curiosity, entrepreneurial agility, and desire to create lasting value for clients. Powered by our purpose – the relentless pursuit of a world that works better for people – we serve and transform leading enterprises, including the Fortune Global 500, with our deep business and industry knowledge, digital operations services, and expertise in data, technology, and AI. 

Get to know us at genpact.com and on LinkedInXYouTube, and Facebook

MEDIA CONTACT:

Sue Martenson
Genpact Media Relations 
+1 978-905-9582
susan.martenson@genpact.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/genpact-and-stada-renew-multi-year-partnership-to-enhance-finance-operations-302245419.html

SOURCE Genpact Ltd.

FAQ

What is the purpose of Genpact and STADA's renewed partnership?

The renewed partnership aims to derisk, scale, and simplify STADA's finance operations, driving competitive advantages through enhanced automation, process-harmonization, and implementation of advanced technologies.

How has Genpact (NYSE: G) improved STADA's financial operations since 2019?

Genpact has leveraged automation and process-harmonization to enhance critical operations, implementing technologies like Cora APFlow to improve accuracy in accounts payable and receivable, streamline data transparency, and allow STADA's teams to focus on strategic initiatives.

What specific technologies are Genpact and STADA implementing in their partnership?

Genpact and STADA are implementing technologies such as Genpact's Cora APFlow for process automation, and are collaborating on implementing advanced tools like S4HANA and generative AI to further enhance financial operations.

How does the partnership between Genpact (NYSE: G) and STADA benefit STADA's internal teams?

The partnership allows STADA's internal teams to focus on high-value activities by automating end-to-end tasks like procure-to-pay and order-to-cash, improving efficiency and cost-effectiveness in handling these processes.
Genpact Limited

NYSE:G

G Rankings

G Latest News

G Latest SEC Filings

G Stock Data

7.89B
158.24M
0.87%
104.38%
3.99%
Information Technology Services
Services-management Consulting Services
Link
Bermuda
HAMILTON